Background: Home-based primary care for homebound seniors is complex, and practice constraints are unique. No quality-of-care standards exist.
W
ith the declining number of nursing home beds (1), patients' continued preference to remain in the home (2) , and an increasingly aged population, the number of permanently homebound seniors will increase to more than 2 million in 20 years (3) . These patients have difficulty accessing medical care and are increasingly receiving primary care through home-based primary care programs (4). As home-based primary care expands, however, tools to support, measure, and improve quality of care for these complex patients have not been developed. One such tool would be a comprehensive set of evidence-based process quality indicators that is developed by experts in home-based primary care.
The Assessing Care of Vulnerable Elders (ACOVE) project has developed several quality indicator sets for ambulatory geriatric and nursing home patients (5, 6 ). These quality frameworks, however, cannot be simply adopted. Home-based primary care patients have higher mortality rates and shorter life expectancies than the ACOVE-studied populations, with goals of care that focus on quality, rather than prolongation, of life (7) (8) (9) . Home-based primary care programs are often multidisciplinary efforts that emphasize coordination and continuity of care (10) . Furthermore, processes of care vital to high-quality care of the homebound patient may have been overlooked by the ACOVE researchers. Given these findings, the Homebased Primary Care Quality Initiative (HPCQI), a multistep, national expert panel process, was completed. The study, by adapting and expanding on earlier ACOVE work, identified a set of evidence-based process quality indicators that are valid and important to providing highquality primary care to homebound seniors.
METHODS

Setting
The study was conducted at the Mount Sinai Visiting Doctors program of the Mount Sinai Medical Center, New York, New York (11) . The initiative was formally endorsed by the American Academy of Home Care Physicians (AAHCP) Board of Directors in 2005.
ACOVE Overview
The ACOVE project created a comprehensive qualityof-care management program for frail community-dwelling elders (5) , including an evidence-based quality indicator set covering 22 geriatric conditions (12) . The feasibility of using these indicators has been demonstrated (13) .
HPCQI Overview
The HPCQI team used a multistep process for adapting and expanding the ACOVE quality indicators to home-based primary care. First, the study team modified language in the ACOVE community and nursing home quality indicators for the home care setting and eliminated hospital-based quality indicators. Second, the HPCQI team members developed evidence-based quality indicators for constipation and insomnia, 2 conditions that the ACOVE project did not cover but for which homebound
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Improving Patient Care patients have disproportionate morbidity. Third, a homebased primary care quality indicator development expert panel (development panel) assessed the new and modified quality indicators for applicability to the home-based primary care setting. Fourth, a second, discrete panel-the home-based primary care quality indicator evaluation expert panel (evaluation panel)-evaluated the applicable quality indicators for validity and importance. Finally, indicators that were deemed to be valid and important by the evaluation panel were accepted for use in the home-based primary care setting.
To form the panels, we contacted clinicians who were in home-based primary care program administration and quality management, had authored peer-reviewed scholarship in the area of home-based primary care, or had leadership roles within the AAHCP. A group of panelists that were diverse in practice type, location, and setting was a priority. (The Appendix, available at www.annals.org, lists the members of each panel.)
The development panel's primary task was to perform a face validity review through a mailed survey of the ACOVE quality indicators. Panelists rated the indicators as 1) likely to apply equally to the home-based primary care setting as to the nursing home or ambulatory care setting, 2) likely to need modification, or 3) unlikely to apply.
The evaluation panel rated the validity and importance of the applicable quality indicators through 2 rounds of mailed surveys. Panel members used a modified Delphi expert panel group judgment process, which has been shown to be appropriate for translating research from 1 area or study to a different population or setting (14, 15). Our study substituted conference calls and mailed surveys for the face-to-face approach-a modification that is shown to have acceptable reproducibility (16) .
Throughout the study, panel members used widely accepted definitions of "home-based primary care" (17) and "homebound seniors" (18).
Role of the Funding Sources
This project was supported by funds from the Division of State, Community, and Public Health, Bureau of Health Professions, Health Resources and Services Administration, U.S. Department of Health and Human Services and a Geriatric Academic Career Award (Dr. Boal). The funding sources played no role in the design, process, or interpretation of the study or in the decision to submit the manuscript for publication.
RESULTS
Quality Indicator Development Panel
Of the 260 quality indicators evaluated by the development panel, 25 (10%) were rated as inapplicable and were removed from the quality indicator set.
Quality Indicator Evaluation Panel
On the basis of first-round survey results, 19 (8.1%) of the 235 applicable indicators, rated as both invalid and unimportant, were removed from the quality indicator set. One hundred seventy-six indicators, rated as valid and important, were included in the final quality indicator set. Forty (17.0%) indicators received indeterminate evaluations, were discussed by the panelists during 2 conference calls, and were then rerated. Of these rerated indicators, 24 were included and 16 were removed from the final quality indicator set.
Finally, the evaluation panel reviewed the indicators that the development panel eliminated and agreed that they were appropriately excluded.
Final Home-Based Primary Care Quality Indicator Set
The result is a quality indicator set with 200 process indicators for 23 geriatric conditions (Appendix Table, available at www.annals.org). Of these 200 quality indicators, 21 (10.5%) were newly created, 52 (26%) were modified from the ACOVE work, and 127 (63.5%) were unchanged from the ACOVE work. Fifty-five ACOVE indicators and 5 newly created indicators, rated as inapplicable, invalid, and/or unimportant, were dropped from the quality indicator set.
The 21 new indicators were limited to 6 conditions: constipation (n ϭ 9), continuity and coordination of care (n ϭ 3), end-of-life care (n ϭ 2), heart failure (n ϭ 1), insomnia (n ϭ 5), and preventive care (n ϭ 1). The 52 modified indicators fell into 6 categories: documentation (n ϭ 5); earlier screening, intervention, and follow-up (n ϭ 19); more specific or explicit (n ϭ 9); more specific to the home-based primary care setting (n ϭ 6); promoting palliative care or patient autonomy (n ϭ 6); and miscellaneous (n ϭ 7) ( Table 1) . Tables 2 and 3 show selected characteristics of the evaluated indicators. According to domain of care, the highest percentage of rejected indicators was treatmentrelated (51.7%). Accepted indicators were more evenly dispersed among the 4 domains of care.
DISCUSSION
Home-based primary care experts identified a core set of 200 processes that all home-based primary care practitioners should provide for their patients. For our study, we pursued adaptation and expansion of the ACOVE work, rather than adoption or de novo construction. The result is a quality indicator set that overlaps the well-established ACOVE framework with modifications for applicability to the home-based primary care setting.
The modifications, deletions, and additions made during the study demonstrate the unique challenges and preferences of homebound seniors (7) (8) (9) (10) . More than half of the eliminated indicators were from the treatment domain of care. Thus, treatment quality indicators make up a smaller percentage of the overall quality indicator set than
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National Quality-of-Care Standards in Home-Based Primary Care in the original ACOVE work. Quality indicators for follow-up and continuity of care domains, on the other hand, have a higher proportional representation in the quality indicator set. The quality indicator modifications trended toward closer management. Reflecting the reality that homebound patients can decline quickly, many modifications were for more frequent screening and follow-up. Finally, the bulk of the new indicators were in quality-of-life domains, such as end-of-life care, constipation, and insomnia, further reinforcing the primacy placed on patient comfort.
Our most vulnerable seniors are increasingly relying on home-based primary care. Infrastructure to support the provision of high-quality home care is lacking. As such, our quality indicator set fills an essential need. These indicators should guide home-based primary care practitioners as they look to provide high-quality care.
In addition to improving quality, our quality indicator set will allow for future comparative research. An important question, yet unanswered, about home-based primary care is whether the model provides care that is similar in quality to that of more established systems. Without quality-of-care data, the medical community and government payers will probably continue to resist embracing homebased primary care. By creating a quality instrument that Improving Patient Care National Quality-of-Care Standards in Home-Based Primary Care has substantial overlap with work done in other geriatric care settings, comparative quality of care can be studied. Feasibility of implementation could be a limitation to our study. Home-based primary care programs are typically resource-poor and might have difficulty funding quality management infrastructure. Despite these feasibility concerns, all valid and important indicators were reported to encourage home-based primary care programs to search for innovative care solutions and novel funding sources. Future projects to decrease the cost of implementing the quality indicator set should be pursued.
Many home-based primary care patients have severe dementia or fewer than 6 months to live. These patients have different goals of care that render many processes inappropriate. Future studies, such as that completed by ACOVE researchers (19), should identify quality indicators that are not appropriate for these patients.
Another concern, common to expert opinion processes, is that many of these indicators need validation through prospective study. A process for regular update and review of this quality instrument should be coupled with prospective validation. Finally, our quality indicator set represents the expert opinion of a few home-based primary care practitioners. The diversity of the panelists and that they are recognized national experts suggests, however, that their opinions are broadly representative.
Homebound seniors typically have several chronic medical conditions that make providing high-quality primary care both critical and difficult. Using a multistep process, home-based primary care experts identified processes of care that are essential to providing high-quality care to homebound seniors. This quality indicator set should provide a rigorous structure for home-based primary care programs to build their quality-of-care management programs and should improve patient quality of life and longevity. The overlap of the set with previous ACOVE work also allows for future comparative study of quality provided by the home-based primary care model. IF a homebound patient has constipation, THEN the first-line treatment should include increased fiber intake (dietary and/or psyllium) and increased fluid intake unless contraindicated. Second-line treatment IF a homebound patient has constipation that does not respond to fiber or fluid intake, THEN lactulose, polyethylene glycol, or a short trial of a stimulant (senna or bisacodyl) should be tried sequentially until improvement is documented. Disimpaction IF a homebound patient is found to have impacted stool on digital rectal examination, THEN manual disimpaction should be performed, followed by enemas or suppositories as needed.
Continuity and coordination of care
Identify source of care ALL homebound patients and/or the caregiver should be able to identify a provider or a clinic that they would call when in need of medical care or should know the telephone number or other mechanism by which they can reach this source of care. Medication follow-up IF a homebound patient is started on a new prescription medication and he or she has a follow-up visit with the prescribing physician, THEN the medical record at the follow-up visit should document one of the following: 1) that the medication is being taken, 2) that the physician asked about the medication (for example, side effects, adherence, or availability), or 3) that the medication was not started because it was not needed or was changed. Medication continuity between physicians IF a homebound patient is under the outpatient care of 2 or more physicians, and 1 physician has prescribed a new prescription medication or a change in medication (medication termination or change in dosage), THEN subsequent medical record entries by the nonprescribing physician should acknowledge the medication change.
Reason for consultation
IF a homebound patient is referred to a consultant physician, THEN the reason for consultation should be documented in the consultant's note. Document consultant recommendations IF a homebound patient is referred to a consultant and subsequently visits the referring physician after the visit with the consultant, THEN the referring physician's follow-up note should document the consultant's recommendations, or the medical record should include the consultant's note, within 6 weeks or at the time of the follow-up visit, whichever is later. Diagnostic test follow-up IF the outpatient medical record documents that a diagnostic test was ordered for a homebound patient, THEN the medical record at the follow-up visit should document one of the following: 1) the result of the test, 2) that the test was not needed or the reason why it will not be performed, or 3) that the test is still pending. Hospital admission IF a homebound patient is admitted to the hospital or brought to the emergency department, THEN the home care primary care physician should contact the emergency department or the hospital-admitting teams to communicate pertinent clinical information. Medication continuity after hospitalization IF a homebound patient is discharged from a hospital to home and he or she received a new prescription medication or a change in medication (medication termination or change in dosage) before discharge, THEN the outpatient medical record should acknowledge the medication change within 4 weeks of discharge. Continuity of test results between care venues IF a homebound patient is discharged from a hospital to home and the transfer form or discharge summary indicates that a test result is pending, THEN the outpatient record should include the test result within 6 weeks of hospital discharge.
Posthospitalization follow-up appointment IF a homebound patient is discharged from a hospital to home and the hospital medical record specifies a follow-up appointment for a physician visit or a treatment (for example, physical therapy or radiation oncology), THEN the medical record should document that the visit or treatment took place or that it was postponed or was not needed. IF a homebound patient is being treated for depression with antidepressants, THEN the antidepressants should be prescribed at appropriate starting doses, and they should have an appropriate titration schedule to a therapeutic dose, therapeutic blood level, or remission of symptoms by 12 weeks. IF a homebound patient has no meaningful symptom response after 6 weeks of treatment, THEN one of the following treatment options should be initiated by the 8th week of treatment: medication dose should be optimized or the patient should be referred to a psychiatrist (if initial treatment was medication), or medication should be initiated or referral to a psychiatrist should be offered (if initial treatment was psychotherapy alone). IF a homebound patient responds only partially after 12 weeks of treatment, THEN one of the following treatment options should be instituted by the 16th week of treatment: maximize the dose of the selected medication, switch to a different medication class or add a second medication to the first (if initial treatment includes medication), add psychotherapy (if the initial treatment was medication), try medication (if initial treatment was psychotherapy without medication), consider electroconvulsive therapy, or refer to a psychiatrist.
Continuing antidepressant therapy
IF a homebound patient has responded to antidepressant medication, THEN he or she should be continued on the drug at the same dose for at least 6 months and should make at least one clinician contact (home visit or telephone) during that time period. If a homebound patient has experienced three or more episodes of depression, THEN the patient should receive maintenance antidepressant medication for at least 36 months. 
Diabetes
End-of-life care
Advance directives and surrogates ALL homebound patients should have in their outpatient chart one of the following: 1) an advance directive indicating the patient's surrogate decisionmaker, 2) documentation of a discussion about who would be a surrogate decisionmaker or a search for a surrogate, or 3) indication that there is no identified surrogate. IF a homebound patient with dementia, coma, or altered mental status is admitted to the hospital and survives 48 hours, THEN the outpatient medical record should document that the following information was communicated to the inpatient care team within 48 hours of admission: 1) advance directives indicating the patient's surrogate decisionmaker, 2) who could be a surrogate decisionmaker, or 3) there is no identified possible surrogate. Documentation of care preferences IF a homebound patient with severe dementia, coma, or altered mental status is admitted to the hospital and survives 48 hours, THEN the outpatient medical record should document that the patient's prior preferences for care were communicated to the inpatient care team within 48 hours of admission. IF a homebound patient is admitted directly to the intensive care unit (from the outpatient setting or emergency department) and survives 48 hours, THEN the outpatient medical record should document that the patient's prior preferences for care were communicated to the inpatient care team within 48 hours of admission. Preferences about future health states IF a homebound patient indicates (during an interview) that he or she would rather die than live permanently comatose, ventilated, or tube-fed, THEN 1) the chart should document a discussion of life-sustaining treatment preferences, 2) the chart should contain an advance directive, or 3) the patient should indicate (during the interview) that he or she discussed this topic with the physician or does not wish to discuss this. Advance directive continuity IF a homebound patient has an advance directive in the outpatient, inpatient, or nursing home medical record or the patient reports the existence of an advance directive in an interview, and the patient receives care in a second venue, THEN 1) the advance directive should be present in the medical record at the second venue or 2) documentation should acknowledge its existence, its contents, and the reason that it is not in the medical record. Life-sustaining care decisions IF a homebound patient with decision-making capacity has orders written in the hospital, home, or nursing home to withhold or withdraw a particular treatment (for example, a do-not-resuscitate order), THEN the medical record should document 1) patient participation in the decision or 2) why the patient did not participate in the decision. Care consistency with preferences IF a homebound patient has specific treatment preferences (for example, a do-not-resuscitate order, no tube feeding, or no hospital transfer) documented in a medical record, THEN these treatment preferences should be followed. Mechanical ventilator withdrawal IF a noncomatose, homebound patient is not expected to survive and a mechanical ventilator is withdrawn or intubation is withheld, THEN the patient should receive or have orders for an opiate or benzodiazepine or barbiturate infusion to reduce dyspnea, and the chart should document whether the patient has dyspnea. 
Care of the dying patient
Hearing loss
Screening for hearing loss ALL homebound patients should have a documented hearing assessment as part of the initial evaluation.
Formal audiologic evaluation
IF an initial hearing assessment of a homebound patient indicates hearing impairment, the etiology of which cannot be determined by the visiting physician, THEN he or she should be offered a formal audiologic evaluation within 3 months. Ear examination IF a homebound patient has a hearing problem or fails a hearing screening, THEN he or she should have an ear examination within 3 months. Referral to audiologist IF a homebound patient is a hearing aid candidate, THEN he or she should be offered referral to an audiologist within 3 months after audiologic examination.
Heart failure ACE inhibitor use IF a homebound patient has asymptomatic left ventricular dysfunction with a left ventricular ejection fraction of 40% or less, THEN an ACE inhibitor should be offered. IF a homebound patient has symptomatic heart failure and left ventricular ejection fraction of 40% or less, THEN he or she should be offered treatment with an ACE inhibitor. Medical history IF a homebound patient has newly diagnosed heart failure, THEN a history should be taken at the time of diagnosis and hospitalization to document the presence or absence of previous myocardial infarction; coronary artery disease; revascularization; current symptoms of chest pain or angina; history of hypertension, diabetes, hypercholesterolemia, valvular heart disease, or thyroid disease; smoking status; current medications; and functional capacity (for example, New York Heart Association functional status). Physical examination IF a homebound patient has newly diagnosed heart failure, THEN the following physical examination findings should be documented at presentation: body weight (if able to stand); blood pressure; heart rate; and results of lung, cardiac, and abdominal or lower-extremity examination. Diagnostic testing IF a homebound patient has newly diagnosed heart failure, THEN the following studies should be recommended and completed within 1 month of diagnosis in patients with heart failure (unless the tests were performed within the previous 3 months): chest radiography; electrocardiography; complete blood count; and measurement of serum sodium and potassium, serum creatinine, and thyroid-stimulating hormone levels (in patients with atrial fibrillation or heart failure of no obvious etiology). Patient education IF a homebound patient has newly diagnosed heart failure, THEN education about disease management should be provided and documented. Evaluation of ejection fraction IF a homebound patient has newly diagnosed heart failure, THEN evaluation of left ventricular ejection fraction within 1 month should be recommended. ␤-Blocker use IF a homebound patient has heart failure, left ventricular ejection fraction of 40% or less, and New York Heart Association class I to III disease, THEN a ␤-blocker should be offered unless the patient has a documented contraindication (for example, uncompensated heart failure). Calcium-channel blocker use IF a homebound patient has heart failure, left ventricular ejection fraction of 40% or less, and no atrial fibrillation, THEN from among the three generations of calcium-channel blocker medications, he or she should not be treated with a first-or second-generation calcium-channel blocker. Digoxin monitoring IF a homebound patient with heart failure is treated with digoxin, THEN the digoxin level should be checked within 1 week of initiation or dosing change. IF a homebound patient with heart failure is treated with digoxin, THEN the digoxin level should be checked within 1 week if signs of toxicity develop. Atrial fibrillation IF a homebound patient has heart failure and atrial fibrillation, THEN anticoagulation should be offered to achieve an INR of 2.0 to 3.0. IF a homebound patient has heart failure and atrial fibrillation AND documented contraindications to anticoagulation, THEN aspirin should be offered. Follow-up after heart failure hospitalization
If a homebound patient returns to the home after hospitalization for heart failure, THEN he or she should have follow-up that includes weight measurement (if able to stand) within 7 days after hospital discharge.
Hypertension
Cardiovascular risk documentation
IF a homebound patient is newly diagnosed with hypertension, THEN there should be documentation regarding the presence or absence of other cardiovascular risk factors. Ascertaining the hypertension diagnosis IF a homebound patient is diagnosed with hypertension and has a blood pressure below 160/100 mm Hg, THEN there should be evidence that two or more blood pressure measurements of 140/90 mm Hg or greater were obtained before diagnosis.
Physical examination IF a homebound patient is diagnosed with new hypertension, THEN a physical examination within 4 weeks of the diagnosis should include a fundoscopic eye examination, a lung examination, a cardiac examination (including an examination of pulses), an abdominal examination (including assessment for bruits), and an extremity examination. Pharmacologic management IF a homebound patient remains hypertensive after nonpharmacologic intervention, THEN pharmacologic antihypertensive treatment should be initiated. IF a homebound patient requires pharmacotherapy for treatment of hypertension in the outpatient setting, THEN a once-or twice-daily medication should be used unless there is documentation regarding the need for agents that require more frequent dosing. IF a homebound patient has hypertension and has renal parenchymal disease with a serum creatinine concentration greater than 1.5 mg/dL or more than 1 g of protein/24 h of collected urine, THEN therapy with an ACE inhibitor should be offered. IF a homebound patient is diagnosed with hypertension and pharmacologic intervention is initiated, THEN follow-up blood pressure checks should occur every 2 weeks until blood pressure control (Յ140/90 mm Hg) is achieved. IF a homebound patient with hypertension is treated with pharmacologic therapy and has achieved blood pressure control goal, THEN follow-up blood pressure checks should occur at least every 3 months.
Insomnia
Initial evaluation ALL homebound patients should be evaluated for insomnia during an initial evaluation. IF a homebound patient complains of insomnia, THEN a chart review and a targeted history should be completed to identify and treat common comorbid conditions associated with insomnia, such as medication use, depression, substance abuse, poor sleep hygiene, caffeine, chronic pain, cardiopulmonary disease, and/or obstructive sleep apnea. Self-medication IF a homebound patient has symptoms of insomnia, THEN the primary care physician should assess for self-medication with alcohol or over-the-counter antihistamines and recommend discontinuation or avoidance of these agents. Nonpharmacologic therapy IF a homebound patient has insomnia, THEN first-line therapy should be nonpharmacologic and should start with behavioral or cognitive-behavioral therapy. Medication therapy IF a homebound patient has insomnia requiring medication, THEN the use of long-acting benzodiazepines should be avoided.
Ischemic heart disease
Early aspirin therapy IF a homebound patient has symptoms of acute myocardial infarction or unstable angina, THEN he or she should be given aspirin therapy within 1 hour of presentation. Cholesterol level evaluation IF a homebound patient has established coronary heart disease and his or her cholesterol level is not known, THEN he or she should be offered a fasting cholesterol evaluation, including total, LDL, and HDL cholesterol levels. Antiplatelet therapy IF a homebound patient has established coronary heart disease and is not receiving warfarin, THEN he or she should be offered antiplatelet therapy. Smoking cessation IF a homebound patient with established coronary heart disease smokes, THEN he or she should be offered counseling for smoking cessation at every visit and have this offer documented in the medical record. ␤-Blocker therapy IF a homebound patient has had an acute myocardial infarction, THEN he or she should be offered a ␤-blocker. Myocardial infarction transfer to the hospital IF a homebound patient has an acute myocardial infarction by electrocardiography and does not have a do-not-hospitalize or do-not-resuscitate order, THEN he or she should be transferred to the hospital or the record should document why this is not indicated.
Malnutrition
Document weight loss IF a homebound patient has involuntary weight loss of greater than or equal to 10% of body weight over 1 year or less, THEN weight loss (or a related disorder) should be documented in the medical record. Evaluate weight loss and hypoalbuminemia IF a homebound patient has documented involuntary weight loss or hypoalbuminemia (Ͻ 3.5 g/dL), THEN he or she should receive an evaluation for potentially reversible causes of poor nutritional intake.
Evaluate comorbid conditions
IF a homebound patient has documented involuntary weight loss or hypoalbuminemia (Ͻ 3.5 g/dL), THEN he or she should receive an evaluation for potentially relevant comorbid conditions, including medications that might be associated with decreased appetite (for example, digoxin, fluoxetine, anticholinergics), depressive symptoms, and cognitive impairment. 
Medication use
Preventive care
Geriatric evaluation ALL homebound patients newly admitted to a physician practice should receive, within 6 months, the elements of a comprehensive geriatric assessment. Geriatric evaluation follow-up IF the elements of a comprehensive geriatric assessment are performed, THEN follow-up should assure the implementation of recommendations. Alcohol screening ALL homebound patients should be screened at least once to detect problem and/or hazardous drinking by taking a history of alcohol use or by using standardized screening questionnaires (for example, CAGE assessment or AUDIT). Tobacco screening and counseling ALL homebound patients should receive screening for tobacco use and nicotine dependence. ALL homebound patients who smoke should be counseled annually about smoking cessation. IF a homebound patient uses tobacco regularly, THEN he or she should be offered counseling and/or pharmacologic therapy at least once to stop tobacco use. Physical activity screening ALL homebound patients should receive an assessment of their activity level and be provided with counseling at least once to promote regular physical activity. Colorectal cancer screening ALL homebound patients should be offered screening for colorectal cancer at least once with fecal occult blood testing or should have had sigmoidoscopy in the last 5 years or colonoscopy in the last 10 years.
Stroke and atrial fibrillation Carotid artery imaging IF a male homebound patient has carotid artery symptoms and is diagnosed with transient ischemic attack or nondisabling stroke and the medical record does not document that the patient is not a candidate for carotid surgery, THEN a carotid artery imaging study should be offered and performed within 4 weeks. Contraindication IF the combined risk of surgery for a homebound patient (patient characteristics and hospital or surgeon experience) is 10% or greater, THEN carotid endarterectomy should not be performed. Anticoagulation for atrial fibrillation IF a homebound patient has atrial fibrillation for more than 48 hours and has any "high-risk" condition (impaired left ventricular function; female older than 75 years of age; hypertension or systolic blood pressure greater than 160 mm Hg; or prior ischemic stroke, transient ischemic attack, or systemic embolism), THEN he or she should be offered oral anticoagulant therapy or antiplatelet therapy if the medical record documents a reason not to give anticoagulant therapy. Stroke imaging before anticoagulation IF a homebound patient has a presumed stroke, THEN CT or MRI of the head should be recommended and performed before initiation or continuation of thrombolytic treatment, anticoagulant therapy, or antiplatelet therapy. Monitoring warfarin therapy IF a homebound patient is taking warfarin for atrial fibrillation, THEN an INR should be checked within 4 days of the first dose and at least every 6 weeks. Antiplatelet therapy for acute stroke IF a homebound patient is diagnosed with acute atherothrombotic ischemic stroke or with a transient ischemic attack, THEN antiplatelet treatment should be offered within 48 hours after the stroke or transient ischemic attack, unless the patient is already receiving anticoagulant treatment. Smoking cessation IF a homebound patient has a transient ischemic attack or stroke, THEN the medical record should document that smoking status was assessed and that smokers were counseled to stop smoking. Hospitalized for stroke IF a homebound patient is suspected of having a stroke and there is no do-not-hospitalize order or advance directive proscribing transfer to the hospital, THEN the patient should be transferred to a hospital or the chart should document why transfer is not indicated. Rehabiliation for stroke IF a homebound patient has had a stroke with resultant functional disability and meets standard criteria for rehabilitation potential, THEN the patient should be offered formal rehabilitation. Statins IF a homebound patient younger than 70 years of age has sustained a thrombotic stroke or transient ischemic attack and if two lipid measurements at least 2 weeks apart confirm an LDL choleserol level Ͼ130 mg/dL and/or total cholesterol-HDL cholesterol ratio Ͼ4, THEN the patient should be offered treatment.
Urinary incontinence
Initial evaluation ALL homebound patients should have documentation of the presence or absence of urinary incontinence during the initial evaluation.
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